日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader.

对新型蛋白水解靶向嵌合雄激素受体降解剂 Bavdegalutamide (ARV-110) 进行临床前评价

Snyder Lawrence B, Neklesa Taavi K, Willard Ryan R, Gordon Deborah A, Pizzano Jennifer, Vitale Nicholas, Robling Kaitlynn, Dorso Madeline A, Moghrabi Walid, Landrette Sean, Gedrich Richard, Lee Sang Hyun, Taylor Ian C A, Houston John G

Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5

发现和临床前评估 BMS-955829,一种强效的 mGluR5 正向变构调节剂

Yang, Fukang; Snyder, Lawrence B; Balakrishnan, Anand; Brown, Jeffrey M; Sivarao, Digavalli V; Easton, Amy; Fernandes, Alda; Gulianello, Michael; Hanumegowda, Umesh M; Huang, Hong; Huang, Yanling; Jones, Kelli M; Li, Yu-Wen; Matchett, Michele; Mattson, Gail; Miller, Regina; Santone, Kenneth S; Senapati, Arun; Shields, Eric E; Simutis, Frank J; Westphal, Ryan; Whiterock, Valerie J; Bronson, Joanne J; Macor, John E; Degnan, Andrew P

Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes

HCV NS5A抑制剂:从亚氨基噻唑烷酮类到对称芪类

Romine, Jeffrey L; St Laurent, Denis R; Leet, John E; Martin, Scott W; Serrano-Wu, Michael H; Yang, Fukang; Gao, Min; O'Boyle, Donald R 2nd; Lemm, Julie A; Sun, Jin-Hua; Nower, Peter T; Huang, Xiaohua Stella; Deshpande, Milind S; Meanwell, Nicholas A; Snyder, Lawrence B